ChemoCentryx to Participate in the Canaccord Genuity 41st Annual Growth Conference
SAN CARLOS, Calif., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D.,...
Day: August 4, 2021
Sarepta Therapeutics Executes Licensing Agreement for Gene Therapy Program from Nationwide Children’s Hospital to Treat Limb-Girdle Muscular Dystrophy Type 2A
– Limb-girdle muscular dystrophy type 2A is the most common form of LGMD, accounting for a third of LGMD diagnoses...
Daxor’s Blood Volume (BVA-100®) Diagnostic Demonstrates Clinical Utility In Critically-Ill COVID-19 Patients In Newly Published Data in Journal Critical Care
Data Led to Multi-Center Study In Progress At Three Leading Hospitals Oak Ridge, TN, Aug. 04, 2021 (GLOBE NEWSWIRE) --...
Oyster Point Pharma to Report Second Quarter 2021 Financial Results on August 5, 2021
Conference Call and Webcast Scheduled for August 5, 2021, 4:30 p.m. Eastern TimePRINCETON, N.J., Aug. 04, 2021 (GLOBE NEWSWIRE) --...
Artelo Biosciences Announces Publication of Study Results Comparing the Pharmacological Effects of Plant-Derived Versus Synthetic Cannabidiol in Human Cell Lines
Study finds no in-vitro pharmacological difference in the antiproliferative, anti-inflammatory, or permeability effects of purified natural versus synthetic CBD Study...
LifeMD, Inc. Partners With Particle Health to Provide Comprehensive Health Records Offering a More Personalized Approach to Medical Care
- Partnership enables LifeMD to offer best-in-class, personalized medical care by providing providers on the platform a deeper understanding of...
InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update
Earnings conference call to be held Tuesday, August 10, 2021, at 8:30 a.m. ETTEL AVIV, Israel, Aug. 04, 2021 (GLOBE...
Homology Medicines to Participate in Upcoming Investor Conferences
BEDFORD, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a clinical-stage genetic medicines company, announced today...
Better Choice Company Announces Partnership with the Third Largest Pet Specialty Retailer in the U.S., Pet Supplies Plus, for Premiere National Launch of Halo Elevate
Announces 2022 Launch of Ground-Breaking New Brand of Super Premium, Natural Pet FoodNEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) --...
COMPASS Pathways plc to announce second quarter 2021 financial results on 11 August 2021
London, UK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to...
Maitri Health Technologies and Bloom Health Partners Announce Abbas Khan as Chief Marketing Officer
Co-Founder of Bloom Health Partners to lead go-to-market strategy for Testing Services, Occupational Health and Big DataVancouver, British Columbia--(Newsfile Corp....
Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK
The clinic will deliver psychedelic-assisted psychotherapy treatments for Addiction and other mental health conditions and is scheduled to open during...
NeuroPace Launches nSight Platform and Partnership with Seizure Tracker™ to Provide Doctors With Personalized Information About Their Patients’ Seizure Burden
New Online Physician Portal Integrates RNS System’s EEG Data with Patient Seizure Diary App to Help Doctors Provide More Comprehensive,...
HST Pathways Appoints Experienced Technology Executive David Thawley as CEO
Thawley brings 15+ years of experience leading high-growth technology companies HST Pathways Founder Tom Hui to serve as Non-Executive Chairman...
Defence Therapeutics Signs an Agreement with Biopharma Excellence, a Pharmalex GmbH Company, to Maximize and Strategize the Development of Its Accum(TM) Platform and Clinical Trials
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), a biotechnology...
Evotec SE to Announce Results for the First Half-Year 2021 on 11 August 2021
HAMBURG, GERMANY / ACCESSWIRE / August 4, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will announce...